EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Pathophysiology of cardiovascular risk in sleep apnea syndrome (SAS)



Pathophysiology of cardiovascular risk in sleep apnea syndrome (SAS)



Revue Neurologique 158(8-9): 785-797



Different pathophysiological mechanisms underlie the morbid associations observed between sleep apnea syndrome (SAS) and cardiovascular disease. Cardiovascular responses to apnea can be divided into acute cardiovascular modifications following each nocturnal respiratory event and chronic adaptations of the cardiovascular system. The same stimuli always trigger acute cardiovascular response: hypoxemia, hypercapnea, changes in the intra-thoracic pressure, micro-arousals. Each obstructive or central respiratory event is associated with a peak in blood pressure, changes in the heart rate, generally bradycardia at onset of apnea and tachycardia when respiration is renewed. Oxygen desaturation is the strongest stimulus explaining the observed acute cardiovascular responses. When these stimuli are repeated every night, the cardiovascular system adapts with a higher sympathetic tone and lower parasympathetic tone during the diurnal period. Baroreceptors also become less sensitive in apneic patients. Finally, endothelial function is altered in SAS patients with a desensitization of the alpha and beta-2 adrengeric receptors, altered NO-dependent vasodilatation, and hypersensitivity to vasoconstriction induced, for example, by angiotensin 2. The cardiovascular morbidity associated with SAS is currently thought to concern the development of diurnal hypertension (dose-effect response), left ventricular failure, higher risk of coronary or cerebral events. Very recently, epidemiological studies suggested that continuous positive pressure ventilation in SAS patients can reduce the cardiovascular risk.

(PDF 0-2 workdays service: $29.90)

Accession: 046928953

Download citation: RISBibTeXText

PMID: 12386523



Related references

Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 293(4): R1671-R1683, 2007

Obstructive Sleep Apnea Syndrome: Links Betwen Pathophysiology and Cardiovascular Complications. Clinical and Investigative Medicine. Medecine Clinique et Experimentale 38(6): E362-E370, 2016

Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertension Research 29(6): 433-441, 2006

On sleep and death: cardiovascular risk of the obstructive sleep apnea syndrome. Netherlands Journal of Medicine 54(5): 188-190, 1999

Obstructive sleep apnea syndrome and cardiovascular risk. Revue Neurologique 157(11 Pt 2): S42-S45, 2002

Sleep apnea syndrome, hypertension, and cardiovascular risk. Schweizerische Medizinische Wochenschrift 125(47): 2267-2272, 1995

Sleep apnea syndrome: a new cardiovascular risk factor?. Journees Annuelles de Diabetologie de L'hotel-Dieu: 213-224, 2003

The sleep apnea syndrome as a cardiovascular risk factor. Medicina Clinica 102(9): 357-358, 1994

Does the altered cardiovascular variability associated with obstructive sleep apnea contribute to development of cardiovascular disease in patients with obstructive sleep apnea syndrome?. Circulation 100(25): E136-E137, 1999

Obstructive sleep apnea hypopnea syndrome and metabolic syndrome: a synergistic cardiovascular risk factor. Journal of the American Academy of Nurse Practitioners 24(12): 695-703, 2014

Cardiovascular risk in obstructive sleep apnea-hypopnea syndrome (OSA/HS). Archivos de Bronconeumologia 41 Suppl 5: 30-35, 2006

Obstructive sleep apnea syndrome in adults and cardiovascular risk. Annales de Cardiologie et D'angeiologie 41(10): 531-539, 1992

Sleep obstructive apnea syndrome in adults and cardiovascular risk. Annales de Cardiologie et d'Angeiologie 41(10): 531-539, 1992

Cardiovascular risk among adults with obstructive sleep apnea syndrome. Gaceta Medica de Mexico 144(4): 323-332, 2008

Obstructive sleep apnea syndrome: a cardiovascular risk factor?. Zeitschrift für Kardiologie 90(8): 568-575, 2001